SEC FILINGS


Form S-1/A
ACADIA PHARMACEUTICALS INC filed this Form S-1/A on 02/05/2001
Document Outline
Entire Document (425.9 KB)
Subdocument 1 - S-1/A - S-1/A
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - EXPLANATORY NOTE
Page 3 - SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
Page 4 - N/A
Page 5 - CHART
Page 6 - PROSPECTUS OR OF ANY SALE OF OUR COMMON STOCK.
Page 7 - SUMMARY
Page 8 - OUR STRATEGY
Page 9 - THE OFFERING
Page 10 - N/A
Page 11 - RISK FACTORS
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - RISKS RELATED TO THIS OFFERING
Page 21 - N/A
Page 22 - N/A
Page 23 - NOTE REGARDING FORWARD LOOKING STATEMENTS
Page 24 - USE OF PROCEEDS
Page 25 - CAPITALIZATION
Page 26 - DILUTION
Page 27 - N/A
Page 28 - N/A
Page 29 - MANAGEMENT'S DISCUSSION AND ANALYSIS
Page 30 - RESULTS OF OPERATIONS
Page 31 - LIQUIDITY AND CAPITAL RESOURCES
Page 32 - RECENTLY ISSUED ACCOUNTING STANDARDS
Page 33 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Page 34 - BUSINESS
Page 35 - OUR SOLUTION
Page 36 - OUR DRUG DISCOVERY APPROACH
Page 37 - HOW WE USE OUR TECHNOLOGY
Page 38 - N/A
Page 39 - GLAUCOMA
Page 40 - SCHIZOPHRENIA
Page 41 - ALZHEIMER'S DISEASE
Page 42 - OUR RESEARCH PROJECTS
Page 43 - OUR STRATEGY
Page 44 - TECHNOLOGY OVERVIEW
Page 45 - N/A
Page 46 - N/A
Page 47 - COLLABORATION AGREEMENTS
Page 48 - N/A
Page 49 - INTELLECTUAL PROPERTY
Page 50 - COMPETITION
Page 51 - GOVERNMENT REGULATION
Page 52 - EMPLOYEES
Page 53 - FACILITIES
Page 54 - CLINICAL ADVISORY BOARD
Page 55 - N/A
Page 56 - MANAGEMENT
Page 57 - N/A
Page 58 - N/A
Page 59 - BOARD COMPOSITION
Page 60 - COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Page 61 - EMPLOYMENT AGREEMENTS AND INDEBTEDNESS OF MANAGEMENT
Page 62 - OPTION GRANTS IN 2000
Page 63 - 2000 YEAR END OPTION VALUES
Page 64 - N/A
Page 65 - N/A
Page 66 - N/A
Page 67 - RELATED PARTY TRANSACTIONS
Page 68 - N/A
Page 69 - N/A
Page 70 - PRINCIPAL STOCKHOLDERS
Page 71 - N/A
Page 72 - N/A
Page 73 - DESCRIPTION OF CAPITAL STOCK
Page 74 - CHARTER AND BYLAW PROVISIONS
Page 75 - SHARES ELIGIBLE FOR FUTURE SALE
Page 76 - N/A
Page 77 - DIVIDENDS
Page 78 - GAIN ON DISPOSITION OF COMMON STOCK
Page 79 - N/A
Page 80 - UNDERWRITING
Page 81 - N/A
Page 82 - N/A
Page 83 - LEGAL MATTERS
Page 84 - INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page 85 - REPORT OF INDEPENDENT ACCOUNTANTS
Page 86 - CONSOLIDATED BALANCE SHEET
Page 87 - CONSOLIDATED STATEMENT OF OPERATIONS
Page 88 - N/A
Page 89 - N/A
Page 90 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 91 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 92 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 93 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 94 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 95 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 96 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 97 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 98 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 99 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 100 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 101 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 102 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 103 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 104 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 105 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 106 - N/A
Page 107 - SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
Page 108 - N/A
Page 109 - N/A
Page 110 - ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
Page 111 - ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 112 - EXHIBIT
Page 113 - ITEM 17. UNDERTAKINGS
Page 114 - SIGNATURES
Page 115 - N/A
Page 116 - EXHIBIT INDEX
Page 117 - EXHIBIT
Subdocument 2 - EX-10.11 - EXHIBIT 10.11
Page 1 - EXHIBIT 10.11
Page 2 - N/A
Page 3 - Section 5, the security interest of Pledgee shall continue in the Pledged
Page 4 - N/A
Page 5 - N/A
Page 6 - EXHIBIT A
Subdocument 3 - EX-21.1 - EXHIBIT 21.1
Page 1 - LIST OF SUBSIDIARIES
Subdocument 4 - EX-23.1 - EX-23.1
Page 1 - CONSENT OF INDEPENDENT ACCOUNTS